AR093156A1 - Composiciones mucoadhesivas con acido hialuronico y chitosan para aplicacion topica - Google Patents
Composiciones mucoadhesivas con acido hialuronico y chitosan para aplicacion topicaInfo
- Publication number
- AR093156A1 AR093156A1 ARP130103905A ARP130103905A AR093156A1 AR 093156 A1 AR093156 A1 AR 093156A1 AR P130103905 A ARP130103905 A AR P130103905A AR P130103905 A ARP130103905 A AR P130103905A AR 093156 A1 AR093156 A1 AR 093156A1
- Authority
- AR
- Argentina
- Prior art keywords
- chitosan
- treatment
- salts
- topical application
- composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 229920001661 Chitosan Polymers 0.000 title abstract 3
- 230000003232 mucoadhesive effect Effects 0.000 title abstract 2
- 239000002253 acid Substances 0.000 title 1
- 230000000699 topical effect Effects 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical group CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 abstract 2
- 229920002674 hyaluronan Polymers 0.000 abstract 2
- 229960003160 hyaluronic acid Drugs 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 238000002512 chemotherapy Methods 0.000 abstract 1
- 239000000499 gel Substances 0.000 abstract 1
- 150000002315 glycerophosphates Chemical class 0.000 abstract 1
- 239000000017 hydrogel Substances 0.000 abstract 1
- 230000003902 lesion Effects 0.000 abstract 1
- 210000004877 mucosa Anatomy 0.000 abstract 1
- 230000009854 mucosal lesion Effects 0.000 abstract 1
- 238000001959 radiotherapy Methods 0.000 abstract 1
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 abstract 1
- 238000011200 topical administration Methods 0.000 abstract 1
- 230000007704 transition Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0023—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
- A61L26/0052—Mixtures of macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
- A61L26/0061—Use of materials characterised by their function or physical properties
- A61L26/008—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/236—Glycosaminoglycans, e.g. heparin, hyaluronic acid, chondroitin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Preparation (AREA)
Abstract
Composiciones acuosas de ácido hialurónico combinado con chitosán, sus sales y glicerofosfato que tienen propiedades termogelificantes y mucoadhesivas. Estas propiedades permiten su uso para el tratamiento de lesiones de la mucosa mediante administración tópica y, particularmente, para el tratamiento de la mucosa de cavidades corporales, con especial interés en lesiones derivadas de quimioterapia y/o radioterapia para el tratamiento del cáncer. Reivindicación 1: Una composición de ácido hialurónico y sus sales mezclado con chitosán y sus sales y una sal de glicerofosfato en una solución acuosa, caracterizada porque dicha composición tiene una propiedad de transición sol-gel a 35 - 38ºC que a dichas temperaturas forma un hidrogel.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/EP2012/071138 WO2014063735A1 (en) | 2012-10-25 | 2012-10-25 | Mucoadhesive compositions comprising hyaluronic acid and chitosan for topical application |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR093156A1 true AR093156A1 (es) | 2015-05-20 |
Family
ID=47227767
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP130103905A AR093156A1 (es) | 2012-10-25 | 2013-10-25 | Composiciones mucoadhesivas con acido hialuronico y chitosan para aplicacion topica |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP2922581B1 (es) |
| AR (1) | AR093156A1 (es) |
| ES (1) | ES2627868T3 (es) |
| PL (1) | PL2922581T3 (es) |
| TW (1) | TWI639434B (es) |
| WO (1) | WO2014063735A1 (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11623008B2 (en) | 2014-08-20 | 2023-04-11 | Professional Compounding Centers Of America | Excipient compositions for mucoadhesive pharmaceutical compositions including a synergistic combination of amylopectin, pullulan, hyaluronic acid, and xyloglucan |
| US10561680B2 (en) * | 2015-02-26 | 2020-02-18 | Fundació Institut D'investigació En Ciències De La Salut Germans Trias I Pujol | Topical composition for the treatment of mucosal lesions |
| CN105903059A (zh) * | 2016-06-21 | 2016-08-31 | 林春梅 | 一种抑菌医用功能敷料 |
| CN106474050B (zh) * | 2016-11-09 | 2019-10-29 | 中国药科大学 | 一种载有核酸适配体-阿霉素结合物的温敏原位凝胶瘤内注射制剂及其制备方法 |
| CN107099042A (zh) * | 2017-04-17 | 2017-08-29 | 大连理工大学 | 一种温敏型可注射水凝胶的制备方法 |
| JP7123971B2 (ja) * | 2017-04-20 | 2022-08-23 | ゾエティス・サービシーズ・エルエルシー | 乳腺炎を処置する際に使用する動物用組成物、及び関連方法 |
| MX2017017192A (es) * | 2017-12-20 | 2019-06-21 | Gerardo Leyva Gomez | Biopolimero de quitosano y poloxamero 407 obtenido por irradiacion gamma que exhibe propiedades fisicoqumicas y biologicas para la reparacion de heridas. |
| US20210000910A1 (en) | 2019-07-03 | 2021-01-07 | Jysk Skin Solutions Pte Ltd | Topical compositions |
| US12083204B2 (en) | 2022-06-02 | 2024-09-10 | L'oreal | Topical composition for homeostatic delivery of nitric oxide and uses thereof |
| CN118987288B (zh) * | 2024-08-09 | 2025-06-24 | 浙江千里眼医药科技有限公司 | 一种胃肠道造影剂及其制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1212892B (it) | 1983-10-11 | 1989-11-30 | Della Valle Francesco | Acido ialuronico ottenuto per mezzodi filtrazione molecolare sprovvisto di attivita' infiammatoria e sua utilizzazione terapeutica |
| IT1273742B (it) | 1994-08-01 | 1997-07-09 | Lifegroup Spa | Composizioni ad elevata bioadesivita' e mucoadesivita' utili per il trattamento di epitali e mucose |
| CA2212300A1 (en) | 1997-08-04 | 1999-02-04 | Abdellatif Chenite | In vitro or in vivo gelfying chitosan and therapeutic uses thereof |
| US7767656B2 (en) * | 2005-04-25 | 2010-08-03 | Molly S Shoichet | Blends of temperature sensitive and anionic polymers for drug delivery |
| FR2919185B1 (fr) | 2007-07-23 | 2010-09-10 | Ard Sa | Utilisation d'acide hyaluronique pour la preparation de compositions destinees a l'amelioration notamment de l'etat des muqueuses |
-
2012
- 2012-10-25 WO PCT/EP2012/071138 patent/WO2014063735A1/en not_active Ceased
- 2012-10-25 ES ES12791441.4T patent/ES2627868T3/es active Active
- 2012-10-25 PL PL12791441T patent/PL2922581T3/pl unknown
- 2012-10-25 EP EP12791441.4A patent/EP2922581B1/en active Active
-
2013
- 2013-10-24 TW TW102138365A patent/TWI639434B/zh active
- 2013-10-25 AR ARP130103905A patent/AR093156A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2627868T3 (es) | 2017-07-31 |
| PL2922581T3 (pl) | 2017-09-29 |
| EP2922581A1 (en) | 2015-09-30 |
| TWI639434B (zh) | 2018-11-01 |
| WO2014063735A1 (en) | 2014-05-01 |
| EP2922581B1 (en) | 2017-03-15 |
| TW201429478A (zh) | 2014-08-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR093156A1 (es) | Composiciones mucoadhesivas con acido hialuronico y chitosan para aplicacion topica | |
| CO2017005995A2 (es) | Composiciones para el cuidado bucal y métodos de uso | |
| BR112016012862A2 (pt) | formulações para vacinas para neoplasia | |
| CO2017008088A2 (es) | Composiciones para el cuidado bucal y métodos de uso | |
| MX2021010033A (es) | Composiciones microencapsuladas de cannabinoides. | |
| CL2015002710A1 (es) | Composiciones de arni contra el componente c5 del complemento y métodos para su uso. | |
| BR112016014410A2 (pt) | terapia de combinação com vacina de neoantígeno | |
| BR112015022047A8 (pt) | uso de uma composição compreendendo nanopartículas contendo um fármaco da família limo e uma albumina | |
| MX2015008627A (es) | Derivados de acido boronico y usos terapeuticos de los mismos. | |
| BR112015022782A2 (pt) | composto, composição farmacêutica, combinação, e, uso de um composto | |
| MX2016011810A (es) | Composiciones farmaceuticas de compuestos terapeuticamente activos y sus metodos de uso. | |
| BR112015018438A2 (pt) | anticorpo contra c5 e método para prevenir e tratar doenças relacionadas a complemento | |
| CL2014003503A1 (es) | Composición farmacéutica para uso intramamario que comprende un ácido fosfónico y al menos un agente antimicrobiano; y uso para el tratamiento o prevención de mastitis en mamífero no humano. | |
| BR112015008954A2 (pt) | composições de ciclodextrina alquilatada e processos para preparação e uso das mesmas | |
| TN2015000371A1 (en) | Substituted imidazopyridazines | |
| BR112017012406A2 (pt) | formulação com relação fixa de insulina glargina/lixisenatida | |
| BR112016015851A2 (pt) | Formulações farmacêuticas estabilizadas de insulina aspart | |
| BR112015026238A8 (pt) | composto dihidropirazino-pirazina, composição farmacêutica que o compreende, uso do composto, métodos para inibir ou medir a fosforilação e para inibir a atividade da proteína quinase, bem como kit | |
| DOP2016000118A (es) | Tienopirimidinas como inhibidores mknk1 y mknk2 | |
| BR112015031417A2 (pt) | forma de dosagem farmacêutica, composição farmacêutica, métodos para tratamento de um paciente com necessidade de cisteamina e para preparo de uma forma de dosagem | |
| DOP2016000007A (es) | Pirazolpiridinas sustituidas | |
| MX2016000294A (es) | Composicion farmaceutica para liberacion sostenida de lanreotida. | |
| MX2016003238A (es) | Composiciones antisepticas cationicas. | |
| UY35771A (es) | Tienouracil-carboxamidas cíclicas y su uso | |
| ECSP15033898A (es) | Composición antifúngica tópica para el tratamiento de onicomicosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |